New PD-1 Inhibitor Approved for Nasopharyngeal Carcinoma

(MedPage Today) -- The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma (NPC) in adults. No trade name was indicated for the drug.
The first indication -- for the first...